Active, not recruitingPhase 1NCT04262167

Human Autologous Lung Stem Cell Transplant for Idiopathic Pulmonary Fibrosis

Studying Idiopathic pulmonary fibrosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of North Carolina, Chapel Hill
Principal Investigator
Leonard Lobo, MD
University of North Carolina, Chapel Hill
Intervention
Lung Spheroid Stem Cells 100 million(biological)
Enrollment
24 enrolled
Eligibility
40-80 years · All sexes
Timeline
2020 – 2027

Study locations (1)

Collaborators

North Carolina State University

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04262167 on ClinicalTrials.gov

Other trials for Idiopathic pulmonary fibrosis

Additional recruiting or active studies for the same condition.

See all trials for Idiopathic pulmonary fibrosis →

← Back to all trials